Stock SBFM SUNSHINE BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Sunshine Biopharma, Inc.

Equities

SBFM

US8677816014

Real-time Estimate Cboe BZX
Other stock markets
 18:54:25 29/04/2024 BST 		5-day change 1st Jan Change
0.858 USD -9.68% Intraday chart for Sunshine Biopharma, Inc. -46.18% -96.50%
04-19 Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product MT
04-19 Top Premarket Decliners MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sunshine Biopharma Shares Slump After Reverse Stock Split Announcement
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Sunshine Biopharma, Inc. Announces Executive Changes
Sunshine Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Jewish General Hospital Announces Termination of the Research Agreement with Sunshine Biopharma, Inc
Sunshine Biopharma Gets Extension to Comply With Nasdaq Minimum Bid Price Rule
Sunshine Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Wall Street Set to Open Higher; Import Prices Rebound More Than Expected
Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Sunshine Biopharma, Inc. Signs Exclusive Worldwide License with University of Arizona for PLpro-Based Covid-19 Treatment
Sector Update: Health Care Stocks Rise on Friday
Sunshine Biopharma Signs Research Deal with Canadian Hospital for Anticancer Compound; Shares Rise
Sunshine Biopharma Signs Research Agreement with the Jewish General Hospital to Advance the Development of Adva-27A Anticancer Compound
Sunshine Biopharma Signs Research Agreement with the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound
Sunshine Biopharma Launches $2 Million Share Buyback Program; Shares Down Pre-Bell
Sunshine Biopharma, Inc. announces an Equity Buyback for $2 million worth of its shares.
Sunshine Biopharma, Inc. authorizes a Buyback Plan.
Sunshine Biopharma Collaborates With Unnamed Lipid Nanoparticle Company to Develop Anticancer Macromolecule K1.1
Sunshine Biopharma Enters into Collaboration Agreement with Lipid Nanoparticle Formulation Company for K1.1 Anticancer mRNA Project
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SBFM Stock
  4. News Sunshine Biopharma, Inc.
  5. Other languages